Evaluation of Botulinum Toxin A Therapy in Children With Adductor Spasm by Gross Motor Function Measure

Abstract

Intramuscular injection of botulinum neurotoxin A is a relatively new method for treating spastic movement disorders in children. One major goal of any therapy for patients with movement disorders is to improve gross motor function. In this study, 18 patients with adductor spasm were treated with botulinum neurotoxin A. Treatment effect was determined with the Gross Motor Function Measure, a standardized, validated instrument designed to assist in assessment of gross motor function. Spastic muscle hyperactivity and joint mobility were evaluated by the modified Ashworth Scale and by range of motion, respectively. Compared to pretreatment values, significant improvement in gross motor function ( P < .010), decrease in the modified Ashworth Scale, and increase in the range of motion (P < .010) were achieved. Patients with moderate impairment of gross motor function (classed at level III and level IV in the Gross Motor Function Classification System) benefited most from treatment. In patients with severe handicap (level V), only one of five treated patients showed improvement in gross motor function. Nevertheless, all patients in this subgroup benefited from improved ease in hygienic care. In conclusion, we have demonstrated that for most children with moderate functional impairment, the Gross Motor Function Measure is a useful instrument for objective documentation of improvements of gross motor function following treatment with botulinum neurotoxin A. (J Child Neurol 2000;15:214-217).

Get full access to this article

View all access options for this article.

References

Cosgrove AP , Corry IS , Graham HK : Botulinum toxin in the management of the lower limb in cerebral palsy . Dev Med Child Neurol 1994;36:386-396.

Heinen F. , Wissel J. , Philipsen A. , et al: Interventional neuropediatrics: Treatment of dystonic and spastic muscular hyperactivity with botulinum toxin A. Neuropediatrics 1997;28:307-313.

Mall V. , Heinen F. , Linder M. , et al: Treatment of cerebral palsy with botulinum toxin A: Functional benefit and reduction of disability. Three case reports. Pediatr Rehabil 1997;1:235-237.

Schiavo G. , Benfenati F. , Poulain B. , et al: Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 1992;359:832-835.

Ketelaar M. , Vermeer A. : Functional motor abilities of children with cerebral palsy: A systematic literature review of assessment measures. Clin Rehabil 1998;12:369-380.

Russell D. , Rosenbaum P. , Gowland C. , et al: Gross Motor Function Measure Manual. Hamilton, ON, McMaster University, 1998.

Russell DJ , Rosenbaum PL , Cadman DT , et al: The gross motor function measure: A means to evaluate the effects of physical therapy. Dev Med Child Neurol 1989;31:341-352.

Palisano R. , Rosenbaum P. , Walter S. , et al: Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997;39:214-223.

Ashworth B. : Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 1966;192:540-542.

10.

Bohannon RW , Smith MB : Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987 ;67:206-207.

11.

Haley SM , Coster WJ , Ruth MF : A content validity study of the pediatric evaluation of disability inventory. Pediatr Phys Ther 1991;3: 177-184.

12.

Almeida GL , Campbell SK , Girolami GL , et al: Multidimensional assessment of motor function in a child with cerebral palsy following intrathecal administration of Baclofen. Phys Ther 1997;77: 751-764.

13.

Boyce WF , Gowland C. , Rosenbaum P. , et al: Gross motor performance measure for children with cerebral palsy: Study design and preliminary findings. Can J Public Health 1992;83:34-40.

14.

Campbell SK , Kolobe TH , Osten ET , et al: Construct validity of the test of infant motor performance. Phys Ther 1995;75: 585-596.

15.

Damiano DL , Abel MF : Relation of gait analysis to gross motor function in cerebral palsy . Dev Med Child Neurol 1996;38:389-396.

16.

Damiano DL , Abel MF : Functional outcomes of strength training in spastic cerebral palsy . Arch Phys Med Rehabil 1998;79:119-125.

17.

Drouin LM , Malouin F. , Richards CL , Marcoux S. : Correlation between the gross motor function measure scores and gait spatiotemporal measures in children with neurological impairments. Dev Med Child Neurol 1996;38:1007-1019.

18.

Hays RM , McLaughlin JF , Bjornson KF , et al: Electrophysiological monitoring during selective dorsal rhizotomy, and spasticity and Gross Motor Function Measure performance. Dev Med Child Neurol 1998;40:233-238.

19.

Hodgkinson I. , Berard C. , Jindrich ML , et al: Selective dorsal rhizotomy in children with cerebral palsy. Results in 18 cases at one year postoperatively. Stereotact Funct Neurosurg 1997;69:259-267.

20.

Kolobe TH , Palisano RJ , Stratford PW : Comparison of two outcome measures for infants with cerebral palsy and infants with motor delays. Phys Ther 1998 ;78:1062-1072.

21.

Law M. , Russell D. , Pollock N. , et al: A comparison of intensive neurodevelopmental therapy plus casting and a regular occupational therapy program for children with cerebral palsy . Dev Med Child Neurol 1997;39:664-670.

22.

McLaughlin JF , Bjornson KF , Astley SJ , et al: Selective dorsal rhizotomy: Efficacy and safety in an investigator-masked randomized clinical trial. Dev Med Child Neurol 1998;40:220-232.

23.

Nordmark E. , Hagglund G. , Jarnlo GB : Reliability of the gross motor function measure in cerebral palsy. Scand J Rehabil Med 1997 ;29:25-28.

24.

Palisano RJ , Kolobe TH , Haley SM , et al: Validity of the Peabody Developmental Gross Motor Scale as an evaluative measure of infants receiving physical therapy . Phys Ther 1995 ;75:939-948.

25.

Parker DF , Carriere L. , Hebestreit H. , et al: Muscle performance and gross motor function of children with spastic cerebral palsy. Dev Med Child Neurol 1993;35:17-23.

26.

Rosenbaum PL : Selective dorsal rhizotomy studies, letter . Dev Med Child Neurol 1998;40:717.

27.

Russell D. , Palisano R. , Walter S. , et al: Evaluating motor function in children with Down syndrome: Validity of the Gross Motor Function Measure. Dev Med Child Neurol 1998;40:693-701.

28.

Steinbok P. , Reiner AM , Beauchamp R. , et al: A randomized clinical trial to compare selective posterior rhizotomy plus physiotherapy with physiotherapy alone in children with spastic diplegic cerebral palsy . Dev Med Child Neurol 1997;39:178-184.

29.

Steinbok P. , Reiner AM , Kestle JR : Therapeutic electrical stimulation following selective posterior rhizotomy in children with spastic diplegic cerebral palsy: A randomized clinical trial. Dev Med Child Neurol 1997;39:515-520.

30.

Wright FV , Sheil EM , Drake JM , et al: Evaluation of selective dorsal rhizotomy for the reduction of spasticity in cerebral palsy: A randomized controlled trial. Dev Med Child Neurol 1998;40: 239-247.

31.

Wright MJ , Halton JM , Martin RF , Barr RD : Long-term gross motor performance following treatment for acute lymphoblastic leukemia. Med Pediatr Oncol 1998;31:86-90.